Lalitha Vijayakrishnan
Lalitha has over 15 years of pharmacology and integrated drug discovery experience in autoimmune dis...
Bengaluru, Karnataka, India
*50 free lookup(s) per month.
No credit card required.
Lalitha Vijayakrishnan’s Email lalitha.vijayakrishnan@daiichisankyo.com
Social Media
Lalitha Vijayakrishnan’s Location Bengaluru, Karnataka, India
Lalitha Vijayakrishnan’s Current Industry Eurofins Advinus
Lalitha Vijayakrishnan’s Prior Industry Presude Lifesciences | Syngene International | Daiichi Sankyo | Ranbaxy Laboratories | Ranbaxy | Harvard Medical School
Not the Lalitha Vijayakrishnan you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Eurofins Advinus
Senior Director and Head, Discovery Biology, Discovery Services
2022-08-01 00:00:00 - Present
Presude Lifesciences
Co-Founder and Director
2021-10-01 00:00:00 - 2022-08-01 00:00:00
Syngene International
Head-Biology (Integrated drug discovery services)
2020-04-01 00:00:00 - 2021-10-01 00:00:00
Daiichi Sankyo
Assistant Director ( Pharmacology)
2014-03-01 00:00:00 - 2017-04-01 00:00:00
Ranbaxy Laboratories
Group Leader, Department of Pharmacology
2007-01-01 00:00:00 - 2010-06-01 00:00:00
Ranbaxy
Senior Research Scientist
2005-04-01 00:00:00 - 2007-01-01 00:00:00
Harvard Medical School
Postdoctoral Research Associate
2000-04-01 00:00:00 - 2005-12-01 00:00:00Skills
Languages
FAQ About Lalitha Vijayakrishnan
-
Lalitha Vijayakrishnan is located at
Bengaluru, Karnataka, India -
Lalitha Vijayakrishnan is a Lalitha has over 15 years of pharmacology and integrated drug discovery experience in autoimmune disorders, inflammation and cancer. She was most recently Section Head (In vitro Pharmacology, Discovery Services) at Syngene International. Prior to that Lalitha established the Genomics and Translational Sciences business unit at Syngene International, that provided immuno-oncology and translational services. Her team collaborated with major pharma companies like Janssen, GSK and Merck for establishing preclinical proof-of-concept for next-generation antibody therapeutics including engineered mAbs, nanobodies, bispecifics, ADCs as well as cell therapies such as CAR-Ts. From 2005 – 2017, Dr. Lalitha served as Assistant Director at the Daiichi Sankyo Life Science Research Center where she led a department focused on discovery of innovative small molecule therapies for oncology and autoimmunity. Dr. Vijayakrishnan completed her postdoctoral training from Harvard Medical School’s Brigham and Women’s Hospital (Boston, MA, USA) where she worked on elucidating mechanisms of genetic susceptibility to autoimmune disorders. Lalitha has a PhD in Immunology from the International Centre for Genetic Engineering and Biotechnology (ICGEB, New Delhi, India) and an MBA from the Faculty of Management Studies (New Delhi, India). She has authored multiple publications in peer reviewed journals and is co-inventor on several patents.Skilled in Cell Culture, Pharmacology, and Cancer Immunotherapy. Strong business development professional graduated from Faculty of Management Studies - University of Delhi.
-
Lalitha Vijayakrishnan currently works in the Eurofins Advinus |
-
No Languages Available
-
Lalitha Vijayakrishnan has prior
experience in the following industries:
Presude Lifesciences | Syngene International | Daiichi Sankyo | Ranbaxy Laboratories | Ranbaxy | Harvard Medical School -
Lalitha Vijayakrishnan has the following professional experience:
Eurofins Advinus | Presude Lifesciences | Syngene International | Daiichi Sankyo | Ranbaxy Laboratories | Ranbaxy | Harvard Medical School -
You can view Lalitha Vijayakrishnan’s LinkedIn profile at LinkedIn URL
-
Lalitha Vijayakrishnan’s work email
addresses are
lalitha.vijayakrishnan@daiichisankyo.com -
Eurofins Advinus |
People you may be interested in
-
Peter Klijn
-
Rodrigo Weisser
Manager Finance Debiteuren en Crediteuren
Ingeniero, 20 años de experiencia en el área operativa ,...